These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 342154

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Invasive African nontyphoidal Salmonella requires high levels of complement for cell-free antibody-dependent killing.
    Goh YS, MacLennan CA.
    J Immunol Methods; 2013 Jan 31; 387(1-2):121-9. PubMed ID: 23085530
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alternative pathway of complement in sickle cell disease.
    Strauss RG, Asbrock T, Forristal J, West CD.
    Pediatr Res; 1977 Apr 31; 11(4):285-9. PubMed ID: 846782
    [Abstract] [Full Text] [Related]

  • 5. Bactericidal activity of human sera with a physiologic or genetic defect of the complement system.
    Jankowski S, Grzybek-Hryncewicz K, Kopeć W, Zalewski J, Zielinsk SA.
    Acta Microbiol Pol; 1988 Apr 31; 37(3-4):309-15. PubMed ID: 2470241
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 31; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 8. [Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal].
    Dieye TN, Ndiaye O, Ndiaye AB, Thiam D, Fall-Seck K, Diop S, Diop BM, Fall M, Diakhaté L.
    Dakar Med; 1999 Nov 31; 44(2):175-9. PubMed ID: 11957280
    [Abstract] [Full Text] [Related]

  • 9. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 31; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 10. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T, Frisk A, Purvèn M, Nilsson LA.
    Microb Pathog; 1995 Jan 31; 18(1):37-51. PubMed ID: 7783597
    [Abstract] [Full Text] [Related]

  • 11. The role of complement and antibodies in the impaired bactericidal activity of neonatal sera against gram-negative bacteria.
    Jankowski S.
    Acta Microbiol Pol; 1995 Jan 31; 44(1):5-14. PubMed ID: 7660858
    [Abstract] [Full Text] [Related]

  • 12. Impaired bactericidal activity of serum of a child suffering from focal proliferative glomerulonephritis.
    Jankowski S, Galar A, Grzybek-Hryncewicz K, Walczuk M.
    Acta Microbiol Pol; 1991 Jan 31; 40(1-2):65-70. PubMed ID: 1725093
    [Abstract] [Full Text] [Related]

  • 13. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P, McRill CM, Ross SC.
    J Immunol; 1988 Dec 01; 141(11):3902-9. PubMed ID: 3141507
    [Abstract] [Full Text] [Related]

  • 14. The mechanism of bactericidal action of normal human serum against Salmonella rods.
    Mokracka-Latajka G, Jankowski S, Grzybek-Hryncewicz K, Krzyzanowska B.
    Acta Microbiol Pol; 1996 Dec 01; 45(2):169-80. PubMed ID: 8997694
    [Abstract] [Full Text] [Related]

  • 15. Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States.
    Trebicka E, Jacob S, Pirzai W, Hurley BP, Cherayil BJ.
    Clin Vaccine Immunol; 2013 Oct 01; 20(10):1491-8. PubMed ID: 23803904
    [Abstract] [Full Text] [Related]

  • 16. Serum bactericidal activity against Neisseria meningitidis in patients with C3 nephritic factors is dependent on IgG allotypes.
    Skattum L, Gullstrand B, Holmström E, Oxelius VA, Truedsson L.
    Clin Immunol; 2008 Oct 01; 129(1):123-31. PubMed ID: 18667363
    [Abstract] [Full Text] [Related]

  • 17. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis.
    Akalin HE, Laleli Y, Telatar H.
    Q J Med; 1985 Aug 01; 56(220):431-7. PubMed ID: 3901076
    [Abstract] [Full Text] [Related]

  • 18. Impaired bactericidal activity of cord sera against Salmonella strains.
    Jankowski S, Konrad A, Grzybek-Hryncewicz K.
    Arch Immunol Ther Exp (Warsz); 1983 Aug 01; 31(2):249-53. PubMed ID: 6360075
    [Abstract] [Full Text] [Related]

  • 19. Opsonization of Salmonella enteritidis lipopolysaccharide in sickle cell disease.
    Field RJ, Overturf GD, Strunk R.
    Pediatr Res; 1981 Feb 01; 15(2):107-11. PubMed ID: 7019833
    [No Abstract] [Full Text] [Related]

  • 20. Serum immunoglobulin and complement levels in patients with sickle cell anaemia from eastern province of Saudi Arabia.
    Al-Awamy BH, Niazi GA, Al-Mouzan MI, Al-Nahdi M, Naeem MA, Sumer T.
    Trop Geogr Med; 1988 Jan 01; 40(1):13-6. PubMed ID: 3381310
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.